US Bancorp’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

US Bancorp’s Portfolio CMPI Stock Details CMPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,000	Closed	-$6K	–	4327
2022 Q1	$6K	Hold	2,000	–	–	﹤0.01%	3580
2021 Q4	$6K	Hold	2,000	–	–	﹤0.01%	3617
2021 Q3	$8K	Hold	2,000	–	–	﹤0.01%	3542
2021 Q2	$12K	Buy	+2,000	New	+$14.1K	﹤0.01%	3355

US Bancorp's CMPI Position: Q2 2022 in Review

US Bancorp sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q2 2022, closing a stake of 2,000 shares — an estimated $6K sold.

US Bancorp first reported a position in CMPI in Q2 2021 and held it in 4 quarters. The position peaked at $12K in Q2 2021. 0 funds tracked by Wall St. Rank hold CMPI as of Q2 2022.

US Bancorp reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
US Bancorp sold 2,000 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $6K.
US Bancorp first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
US Bancorp's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $12K in Q2 2021.
0 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on US Bancorp's 13F filing for Q2 2022, filed 1 Aug 2022.